JPMorgan resets LLY stock target on drug demand

Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as…

Lilly quietly hands Chinese partner its cancer drug

Eli Lilly (LLY) climbed to new record highs in the final week of June, driven by…

How Medicare's New GLP-1 Pilot Could Change Drug Costs for Beneficiaries and Employees

Medicare beneficiaries may soon have a less expensive way to obtain certain GLP-1 medications prescribed for…

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK…

Molecule to Medicine: How Daraxonrasib is Rewriting Pancreatic Cancer Drug Development

Monash University’s Andrew R. Snyder, PhD. joins the show to discuss Daraxonrasib, a novel RAS(ON) inhibitor,…

Congo seeks experimental Ebola drug as cases surpass 1 000

The Democratic Republic of Congo is seeking access to an experimental antibody treatment targeting multiple Ebola…

Exclusive: Ex-Palantir execs raise $12 million for AI drug discovery startup Perceptic

A trio of former Palantir executives who helped spearhead that company’s Life Sciences practice have founded…